
Lipocine LPCN
€ 1.34
-3.29%
Lipocine ROA | LPCN
ROA Jährlich Lipocine
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -56.63 | 0.04 | -71.08 | -28.66 | -1.21 | -82.69 | -66.17 | -55.92 | -21.05 | -69.38 | -40.13 | -72.78 | -22.97 | 69.83 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 69.83 | -82.69 | -37.06 |
ROA Vierteljährlich Lipocine
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -48.18 | -57.18 | -55.28 | -40.8 | -32.88 | -23.77 | -25.22 | -26.05 | -60.84 | -61.76 | -48.43 | -59.81 | -55.83 | -35.07 | -29.66 | -25.61 | 4.38 | 2.86 | -5.33 | -4.67 | -46.51 | -56.31 | -69.0 | -89.83 | -88.78 | -89.0 | -79.32 | -65.85 | -64.58 | -57.77 | -53.2 | -47.76 | -53.34 | -60.41 | -69.25 | -78.52 | -68.32 | -62.25 | -61.61 | -69.38 | -68.75 | -70.07 | -56.9 | -43.06 | -47.47 | -59.22 | -63.84 | -52.04 | -61.56 | -56.29 | -13727101.38 | -14022227.3 | -14022233.15 | -14185065.77 | -468607.72 | -184081.26 | -184081.79 | -21255.74 | -10611.96 | -15.91 | -15.91 | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.38 | -14185065.77 | -931604.87 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Repare Therapeutics
RPTX
|
-47.98 | - | - | $ 112 M | ||
|
Sesen Bio
SESN
|
-198.56 | - | 7.29 % | $ 127 M | ||
|
Windtree Therapeutics
WINT
|
-6.41 | - | - | $ 26.8 M | ||
|
Trean Insurance Group
TIG
|
-4.17 | - | - | $ 316 M | ||
|
SQZ Biotechnologies Company
SQZ
|
-79.54 | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
-166.66 | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
-98.29 | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Lyra Therapeutics
LYRA
|
-80.09 | - | - | $ 24.9 M | ||
|
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | ||
|
Applied Therapeutics
APLT
|
-121.84 | - | - | $ 8.42 M | ||
|
ESSA Pharma
EPIX
|
-22.28 | - | - | $ 8.86 M | ||
|
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
-136.72 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
-27.51 | - | - | $ 5.78 B | ||
|
RAPT Therapeutics
RAPT
|
-54.04 | - | - | $ 2.36 B | ||
|
Annexon
ANNX
|
-74.47 | $ 3.11 | -8.94 % | $ 482 M | ||
|
Acasti Pharma
ACST
|
-11.69 | - | 4.01 % | $ 150 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Galapagos NV
GLPG
|
9.42 | - | - | $ 1.83 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-5.16 | - | -4.36 % | $ 27 M | ||
|
Avenue Therapeutics
ATXI
|
-99.25 | - | -52.27 % | $ 4.45 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-55.34 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Achieve Life Sciences
ACHV
|
-130.77 | $ 6.78 | 0.89 % | $ 296 M | ||
|
Leap Therapeutics
LPTX
|
3.06 | - | 368.57 % | $ 41.9 M | ||
|
Lumos Pharma
LUMO
|
-83.75 | - | - | $ 35.3 M | ||
|
Gamida Cell Ltd.
GMDA
|
-46.76 | - | -18.25 % | $ 5.04 M | ||
|
Axcella Health
AXLA
|
-428.94 | - | -16.42 % | $ 249 M | ||
|
Metacrine
MTCR
|
-77.77 | - | - | $ 24.2 M | ||
|
Zealand Pharma A/S
ZEAL
|
-49.24 | - | 0.52 % | $ 821 M | ||
|
Myovant Sciences Ltd.
MYOV
|
-39.61 | - | -0.04 % | $ 2.62 B | ||
|
Bellerophon Therapeutics
BLPH
|
-249.92 | - | -74.18 % | $ 955 K | ||
|
Idera Pharmaceuticals
IDRA
|
-23.1 | - | -23.04 % | $ 26.6 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Verona Pharma plc
VRNA
|
-36.57 | - | - | $ 69.7 B | ||
|
Atreca
BCEL
|
-62.67 | - | -11.76 % | $ 5.79 M | ||
|
Guardion Health Sciences
GHSI
|
1.33 | - | -0.31 % | $ 3.64 M | ||
|
Opiant Pharmaceuticals
OPNT
|
4.27 | - | - | $ 109 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
ImmunoGen
IMGN
|
-63.89 | - | - | $ 7.92 B | ||
|
Vascular Biogenics Ltd.
VBLT
|
-57.64 | - | -8.77 % | $ 12.4 M | ||
|
Cidara Therapeutics
CDTX
|
-79.06 | - | - | $ 1.41 B | ||
|
Iterum Therapeutics
ITRM
|
-55.55 | - | - | $ 591 K | ||
|
Virpax Pharmaceuticals
VRPX
|
-775.72 | - | -45.12 % | $ 2.85 M | ||
|
Navidea Biopharmaceuticals
NAVB
|
-347.18 | - | -2.99 % | $ 2.47 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-104.58 | - | - | $ 23.9 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-156.23 | - | 31.87 % | $ 1.61 M |